Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.

Name: Αlpha¹ Rigor Record — Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.
Item: Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.
Rating: 94
Author: Αlpha¹

Tumukunde V, Medvedev MM, Tann CJ, Mambule I, Pitt C, Opondo C, Kakande A, Canter R, Haroon Y, Kirabo-Nagemi C, Abaasa A, Okot W, Katongole F, Ssenyonga R, Niombi N, Nanyunja C, Elbourne D, Greco G, Ekirapa-Kiracho E, Nyirenda M, Allen E, Waiswa P, Lawn JE, OMWaNA Collaborative Authorship Group

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 4.25★ (Strong), 0 critical, 2 high issues for “Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 16, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

4.25 / 5

Strong — minor issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingData & code availability partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Problems surfaced3 types

Overstated conclusions2

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Treatment effect not shown to be clinically meaningfulAssessed
Conclusions only partially backed by the presented evidenceAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-conducted and transparently reported randomised controlled trial of kangaroo mother care before stabilisation versus standard care in Ugandan neonates. The main methodological strengths are rigorous randomisation, clear reporting of biological variables, ethical approvals, and statistical methods. The primary weakness is the vague data availability statement and lack of code sharing, which limits reproducibility.

Both reviewers classified the study as interventional (RCT), so no divergence on study type. The evaluation covered all eight dimensions; several sub-criteria were marked not applicable for a human trial (e.g., species/strain, housing, IACUC). The statistics verification recomputed 7 reported tests, all consistent, but this does not certify the entire analysis. The citation check found no retracted or unresolved references.

10 major claims checked against the paper's own evidence: 1 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: effect size not shown to be clinically meaningful.

Recomputed 7 tests: 7 consistent, 0 inconsistent; 3 recomputed directly from the reported test statistics, 4 via agent-written checks.

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites prior research on KMC, including the WHO iKMC trial and the eKMC trial in The Gambia, and acknowledges their strengths and limitations (e.g., underpowering, context differences). The rationale for the study is clearly stated: to address the evidence gap on KMC before stabilisation in sub-Saharan African facilities without neonatal intensive care. Limitations of prior work (e.g., lack of economic evaluations, focus on level 3 hospitals) are explicitly addressed as gaps the current study aims to fill.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 95% conf

The paper clearly establishes the scientific premise by citing prior work on KMC, including the iKMC and eKMC trials, and provides a logical rationale linking the evidence gap to the study objectives.

Evidence

paraphrase[Introduction, paragraph 3]

“One trial coordinated by WHO (the iKMC trial)... reported that immediate KMC led to a 25% reduction in their secondary outcome of mortality within 28 days... Another trial conducted in a level 2 neonatal unit in The Gambia found no reduction in mortality with KMC before stabilisation compared with standard care; however, this study was underpowered because of improvements in the quality of standard care...”

direct quote[Introduction, paragraph 4]

“The findings of these two trials left an evidence gap regarding the effects of immediate KMC at facilities without neonatal intensive care, where most births in LMICs occur, and questions regarding possibly lower impact in sub-Saharan Africa.”